Skip to main content

Why Ginkgo Bioworks Holdings Stock Raced 9% Higher Today

Motley Fool - Tue Sep 17, 5:07PM CDT

Bioengineering specialist Ginkgo Bioworks Holdings(NYSE: DNA) delivered some badly needed good news for investors on Tuesday. Those folks commensurately rewarded the company by trading up its stock during that day's session, and it closed more than 9% higher in price. That was more than enough to crush the broader market that day, at least in respect to the stagnating S&P 500 index.

Two new products introduced

Ginkgo's news was connected with its efforts in the artificial intelligence (AI) sphere. While that technology isn't as hot as it was for investors several months ago, there is still much interest in its power and potential.

The company unveiled two new products on Tuesday linked to AI. The first is a protein large language model (LLM) it developed with its tech industry partner Alphabet's Google Cloud Consulting unit. According to the biotech, this LLM "will give individual researchers and enterprise companies the ability to develop medicines with insights from Ginkgo's private data."

The company also rolled out its model application programming interface (API; a piece of software that allows different applications to work together). The API, which has been made publicly accessible on Ginkgo's website, allows researchers to work effectively with biological AI models, the company said.

Hope for the future

Ginkgo did not provide any financial details -- costs, pricing, etc. -- of either offering. Regardless, it's clear that investors are enthusiastic about its assertive push into AI and its continuing emphasis on the power of tech to aid in the development of medicines. Shareholders will be hoping that management can turn such efforts into meaningful revenue generators before long.

Should you invest $1,000 in Ginkgo Bioworks right now?

Before you buy stock in Ginkgo Bioworks, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Ginkgo Bioworks wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $715,640!*

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. TheStock Advisorservice has more than quadrupled the return of S&P 500 since 2002*.

See the 10 stocks »

*Stock Advisor returns as of September 16, 2024

Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet. The Motley Fool has a disclosure policy.

Paid Post: Content produced by Motley Fool. The Globe and Mail was not involved, and material was not reviewed prior to publication.